Síndrome de pinzamiento costoclavicular: reporte de un caso y revisión de la literatura

Vega Peña, Neil Valentín; Hernández, Eduart Iván Valbuena
April 2013
Iatreia;abr-jun2013, Vol. 26 Issue 2, p215
Academic Journal
Pinch-off syndrome is a rare complication of central venous catheter insertion through the subclavian approach. It is secondary to external compression of the catheter in the costoclavicular angle, which can lead to obstruction, rupture and embolization of its distal fragment. It is usually associated with premonitory radiological and clinical signs. Due to the severe complications of this syndrome, a proper prophylaxis should be done from the moment of insertion until the end of treatment. We present the case of a patient undergoing chemotherapy for adenocarcinoma of the colon, who developed pinch-off syndrome, with rupture and embolization of the distal fragment of the catheter to the right pulmonary artery. Treatment was successful by means of catheterization through the femoral vein.


Related Articles

  • Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies. Stussi, G.; Halter, J.; Tichelli, A.; Meyer-Monard, S.; Buser, A. S.; Arber, C.; Heim, D.; Passweg, J. R.; Rischewski, J.; Paulussen, M.; Gratwohl, A. // Bone Marrow Transplantation;Jan2010, Vol. 45 Issue 1, p103 

    The prognosis of patients with poor-risk or relapsed hematological malignancies is dismal. The dose intensification necessary to achieve subsequent CR is limited by the toxicity of chemotherapy. Treatment intensification with double allogeneic HSCT (dHSCT) may enhance the antileukemic effect and...

  • Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice. V Gebbia; E Maiello; F Giuliani; N Borsellino; M Caruso; G Di Maggio; F Ferraù; R Bordonaro; F Verderame; P Tralongo; L Di Cristina; R Agueli; P Russo; G Colucci // Annals of Oncology;Jul2007 Supplement 6, Vol. 18, pvi124 

    Background: In daily clinical practice second-line chemotherapy (SLCT) is frequently given to patients with advanced pancreatic cancer failing gemcitabine-based first-line chemotherapy without solid scientific support. Patients and methods: A retrospective survey was carried out including 42...

  • Animal models of human African trypanosomiasis—very useful or too far removed? Kennedy, Peter G.E. // Transactions of the Royal Society of Tropical Medicine & Hygiene;Nov2007, Vol. 101 Issue 11, p1061 

    Summary: Animal models of human African trypanosomiasis, also known as sleeping sickness, have been used for many years both to investigate disease pathogenesis and to test novel drug therapies. Model systems used have included mice, rats and non-human primates such as monkeys. Whilst such...

  • Chemo studies mark new era in prostate Ca care. Williams, Richard D. // Urology Times;Jun2004, Vol. 32 Issue 8, p4 

    Comments on several studies on the effect of chemotherapy in men with metastatic prostate cancer. Strong rationale for the use of chemotherapy in prostate cancer patients; Approval of dacetaxel for use in metastatic, androgen-independent prostate cancer.

  • Is the current concept of recurrent ovarian carcinoma as a chronic disease also applicable in platinum resistant patients? Güth, Uwe; Huang, Dorothy Jane; Schötzau, Andreas; Wight, Edward // Archives of Gynecology & Obstetrics;Mar2010, Vol. 281 Issue 2, p339 

    The treatment of recurrent ovarian carcinoma (ROC) has become increasingly oriented according to the therapy principles of a chronic disease. We evaluated whether it is justifiable to also apply this concept to the treatment of platinum resistant patients with their known poor prognosis and...

  • Recent advances in chemotherapy and chemoradiotherapy for gastrointestinal tract cancers: adjuvant chemoradiotherapy for gastric cancer. Kurokawa, Yukinori; Sasako, Mitsuru // International Journal of Clinical Oncology;Dec2008, Vol. 13 Issue 6, p479 

    Chemoradiotherapy (CRT) is one of the effective modalities for the local control of gastric cancer. Advances in CRT as an adjuvant treatment have been made in the West. The INT0116 trial demonstrated that postoperative chemotherapy with 5-fluorouracil (FU) plus leucovorin and concomitant 45-Gy...

  • A Tough Transition.  // Mayo Clinic Guide to Women's Cancers;2005, p563 

    This article discusses issues cancer patients encounter during the transition from cancer treatment to cancer monitoring. During treatment, patients may feel a sense of comfort in knowing that active steps are being taken to kill the cancer and that he or she being checked frequently. In...

  • Retrospective analysis of prognosis for scirrhous-type gastric cancer: one institution's experience. Nakamura, Rieko; Saikawa, Yoshiro; Wada, Norihito; Yoshida, Masashi; Kubota, Tetsuro; Kumai, Koichiro; Kitajima, Masaki // International Journal of Clinical Oncology;Aug2007, Vol. 12 Issue 4, p291 

    Scirrhous gastric cancer is biologically aggressive, and the prognosis is poor even with curative surgery. We compared outcomes with different therapies in order to identify prognostic factors. Records for 83 patients, who were treated between 1991 and 2004, were evaluated for survival and...

  • Beyond chemotherapy: targeted therapies in ovarian cancer. Yap, Timothy A.; Carden, Craig P.; Kaye, Stan B. // Nature Reviews Cancer;Mar2009, Vol. 9 Issue 3, p167 

    Ovarian cancer is the leading cause of death from gynaecological malignancies in the Western world. Despite the evolution of surgical techniques and meticulously designed chemotherapy regimens, relapse remains almost inevitable in patients with advanced disease. In an age when great advances...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics